About the New York Thoroughbred Horsemen's Association
For over half a century, the New York Thoroughbred Horsemen's Association (NYTHA) has represented the interests of Thoroughbred owners and trainers at New York Racing Association (NYRA) tracks. NYTHA was founded with the objective of serving as a collective voice for the broad interests of New York's horsemen, and to improve and increase the effectiveness of its constituents in the day-to-day business of racing. Today, NYTHA serves as the New York State Gaming Commission's recognized representative of owners and trainers, striving to protect the economic interests of all horsemen and to gain public recognition of horse racing as a vital industry, deserving support, protection and preservation.
The membership of the organization is comprised of any owner or trainer who is licensed by the New York State Gaming Commission and who has run a horse in the last two years at Aqueduct, Belmont or Saratoga.
NYTHA's mission falls into three main areas:
The organization addresses the issues that impact owners and trainers, including purse levels, distribution of gaming revenue, racetrack operations and capital improvements, racing dates and all other concerns important to the future of horse racing in New York. NYTHA works in conjunction with the NYRA, the NYS Gaming Commission, the State Legislature, the Executive Branch, racing industry groups and academic institutions to achieve its goals.
NYTHA is a leader in medication reform, spearheading the Mid-Atlantic Uniform Medication Program, which brings a uniform medication policy and a standardized penalty system to New York and the other states in the region. Under the Program, there are 24 medications classified as Controlled Therapeutic Substances and approved for use in training; all other medications are classified as Prohibited Substances. The Program outlines the appropriate withdrawal times for each of the 24 Therapeutic Substances. The only medication approved for raceday use under the Uniform Medication Program is Furosemide (Lasix).
NYTHA places great emphasis on the Benevolence Program for backstretch employees, which accounts for the organization's largest single expenditure. It includes health, counseling and social services; eyeglass and dental coverage; recreation programs; education including English as a Second Language classes, computer labs and the Groom Development Program; scholarships and college financial aid consultation; and numerous other activities aimed at improving the quality of life on the backstretch.
NYTHA also earmarks funds for equine aftercare, most notably for the two NYTHA-sponsored programs, TAKE THE LEAD Thoroughbred Retirement Program and TAKE2 Second Career Thoroughbred Program. The organization works to promote equine health and safety and to support equine research as well.
In addition, NYTHA: